Chromadex OverviewChromadex EBIT
EBIT (Earnings Before Interest and Taxes) analysis for CDXC.
Quarterly EBIT
$1.58M
↓ 66.97% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
$13.08M
↓ 5% YoY
Trailing 12 months ending Mar 31, 2026
Chromadex OverviewEBIT (Earnings Before Interest and Taxes) analysis for CDXC.
As of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026